GE HealthCare (Nasdaq: GEHC), a medical technology, pharmaceutical diagnostics and digital solutions company , announced on Wednesday that it has launched its Prostate Volume Assist (PVA) AI software feature, enhancing urology imaging and treatment.

PVA automates prostate volume measurements, aiding in prostate cancer detection and management.

The software will be compatible with bkActiv, bk3000/5000 and bkSpecto active imaging systems, supporting clinicians in treatment planning and biopsy guidance.

Prostate cancer, a leading cause of cancer-related deaths globally, necessitates precise diagnosis and management tools like PVA.